Xian Ping Lu
Vorstandsvorsitzender bei SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
Vermögen: 67 Mio $ am 30.04.2024
Aktive Positionen von Xian Ping Lu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Vorstandsvorsitzender | 24.03.2018 | - |
| Vorsitzender | 24.03.2018 | - | |
| Gründer | 21.03.2001 | - | |
| Direktor/Vorstandsmitglied | 21.03.2001 | 24.03.2018 | |
| Technik-/Wissenschafts-/F&E-Leiter | 21.03.2001 | 01.01.2020 | |
| Präsident | 21.03.2001 | 24.03.2018 |
Karriereverlauf von Xian Ping Lu
Ehemalige bekannte Positionen von Xian Ping Lu
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Galderma Research & Development SNC
 Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Corporate Officer/Principal | - | - |
Maxia Pharmaceuticals, Inc.
 Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Gründer | - | - |
Ausbildung von Xian Ping Lu
| Sichuan University | Undergraduate Degree |
| Peking Union Medical College | Graduate Degree |
Statistik
International
| China | 4 |
| Vereinigte Staaten | 2 |
| Frankreich | 2 |
Operativ
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Maxia Pharmaceuticals, Inc.
Maxia Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Incyte Corp., Maxia Pharmaceuticals, Inc. develops pharmaceutical products based on molecule drug discovery techniques. The company is based in San Diego, CA. The company was founded by David Perryman, Xian Ping Lu. Maxia Pharmaceuticals was acquired by Incyte Corp. on February 19, 2003 for $42.30 million. | Commercial Services |
Galderma Research & Development SNC
Galderma Research & Development SNC Pharmaceuticals: MajorHealth Technology Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France. | Health Technology |
- Börse
- Insiders
- Xian Ping Lu
- Erfahrung
